However, serum FSIP1 level was significantly higher in patients with primary breast cancer than in patients with benign cancer (4, 713 ± 3, 065 pg/ml vs. 1, 798 ± 1, 943 pg/ml, p = 0.001). Here, FSIP1 is linked to breast cancer.